Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia.
Rutella S, Vadakekolathu J, Mazziotta F, Reeder S, Yau TO, Mukhopadhyay R, Dickins B, Altmann H, Kramer M, Knaus HA, Blazar BR, Radojcic V, Zeidner JF, Arruda A, Wang B, Abbas HA, Minden MD, Tasian SK, Bornhäuser M, Gojo I, Luznik L.
Rutella S, et al. Among authors: dickins b.
J Clin Invest. 2022 Nov 1;132(21):e159579. doi: 10.1172/JCI159579.
J Clin Invest. 2022.
PMID: 36099049
Free PMC article.